Rdplroyal Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 1195.99%
- Profit Growth 752.05%
- Ebitda 946.00%
- Net Worth 114.66%
- Total Assets 2325.17%
About Rdplroyal Diagnostics
Rdplroyal Diagnostics Private Limited (RDPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 August 2020 (Four years and five months 29 days old ). Its registered office is in Jaipur, Rajasthan, India.
The Corporate was formerly known as Rdcroyal Diagnostic Center Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Prem Devi and Ramnivas Choudhary serve as directors at the Company.
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85200RJ2020PTC070599
- Company No.
070599
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Aug 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Rdplroyal Diagnostics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prem Devi  | Director | 27-Aug-2020 | Current |
| Ramnivas Choudhary | Director | 27-Aug-2020 | Current |
Financial Performance of Rdplroyal Diagnostics.
Rdplroyal Diagnostics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 1195.99% increase. The company also saw a substantial improvement in profitability, with a 752.05% increase in profit. The company's net worth Soared by an impressive increase of 114.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rdplroyal Diagnostics?
Unlock access to Rdplroyal Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rdplroyal Diagnostics?
Rdplroyal Diagnostics has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rdplroyal Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rdplroyal Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.